CARDS
The CARDS project aims to develop and expand tools, services, and training offered to researchers of the Berlin University Alliance (BUA) on the topic of research data management (RDM).
The CARDS project aims to develop and expand tools, services, and training offered to researchers of the Berlin University Alliance (BUA) on the topic of research data management (RDM).
The project "Berlin University Alliance Open Science Magnifiers" continues and further develops the systematic monitoring of Open Science practices. This includes visualizations of indicators for open practices, as well as highlighting of specific best-practice examples.
In INFORM-Stroke, we want to compare the results of a multicentre preclinical stroke study with those of systematic reviews. In addition, more in-depth analyses will examine the effect of animal attrition and of meta-analysis decisions on the effect estimates.
Developing services and infrastructure to support companies in implementing ethical requirements for trustworthy AI products for healthcare.
Navigating towards open and responsible research practice in experimental medicine with the Charité quality compass
Understanding the factors that contribute to poor reproducibility in scientific research, and assessment of the effectiveness of interventions aimed at improving reproducibility.
Leveraging funders' unique position in the research ecosystem to drive improvements in clinical trial transparency in Germany, and beyond.
In this project peer-reviewed literature, documents from health organizations, and websites from health databases will be checked for any guidance aimed at making studies reusing health data more transparent, in order to help identifying any transparency areas for which there is still room for improved guidance.
The Wildling mouse model harbors a natural microbiome allowing researchers to investigate human-like immune system interactions. We aim to evaluate systematically the potential of Wildlings to make an evidence-based decision about the extent of Wildling facilities at Charité.
This project will gain an overview of factors that play a role in the ethical use of real-world data to contribute to the understanding of drug effects.